Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function

Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease with unclear pathogenesis. IPF is considered as a risk factor for lung cancer. Compared to other lung cancers, small-cell lung cancer (SCLC) has a lower incidence, but has a more aggressive course. Patient...

Full description

Bibliographic Details
Main Authors: Xiyue Zhang, Wei Li, Chunyan Li, Jie Zhang, Zhenzhong Su
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Pulmonary Medicine
Subjects:
Small-cell lung cancer
Idiopathic pulmonary fibrosis
Chemotherapy
Online Access:https://doi.org/10.1186/s12890-021-01489-4

Similar Items

Similar Items